URGN icon

UroGen Pharma
URGN

Overview Fund Activity

105 hedge funds and large institutions have $328M invested in UroGen Pharma in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 18 reducing their positions, and 12 closing their positions.

Holders
105
Holders Change
+4
Holders Change %
+3.96%
% of All Funds
1.54%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
16
Increased
50
Reduced
18
Closed
12
Calls
$344K
Puts
$336K
Net Calls
+$8K
Net Calls Change
-$525K

Top Buyers

1
RCM
1
RA Capital Management
Massachusetts
$46.3M
2
RI
2
RTW Investments
New York
$25.9M
3
Morgan Stanley
3
Morgan Stanley
New York
$13.7M
4
BlackRock
4
BlackRock
New York
$25.8M
5
Millennium Management
5
Millennium Management
New York
$6.4M

Top Sellers

1
SCM
1
Soleus Capital Management
Connecticut
$0
2
CI
2
Clal Insurance
Israel
$0
3
EI
3
EAM Investors
California
$0
4
LCM
4
Laurion Capital Management
New York
$3.76M
5
CSS
5
Cubist Systematic Strategies
Connecticut
$2.13K
Name Holding Trade Value Shares
Change 		Shares
Change %
Two Sigma Investments
26
Two Sigma Investments
New York
$1.96M +$158K +10,541 +9%
Point72 Asset Management
27
Point72 Asset Management
Connecticut
$1.89M -$1.23M -81,733 -39%
Cerity Partners
28
Cerity Partners
New York
$1.88M +$1.88M +125,226 New
Goldman Sachs
29
Goldman Sachs
New York
$1.71M +$909K +60,574 +113%
Wellington Management Group
30
Wellington Management Group
Massachusetts
$1.57M +$518K +34,537 +49%
MIH
31
Meitav Investment House
Israel
$1.37M – – –
Renaissance Technologies
32
Renaissance Technologies
New York
$1.37M -$1.04M -69,000 -43%
Nuveen Asset Management
33
Nuveen Asset Management
Illinois
$1.25M +$297K +19,785 +31%
AC
34
Annandale Capital
Texas
$1.23M – – –
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$1.17M +$664K +44,240 +132%
Ameriprise
36
Ameriprise
Minnesota
$1.09M -$197K -13,148 -15%
Bank of America
37
Bank of America
North Carolina
$1.07M +$425K +28,326 +65%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$1.05M +$184K +12,298 +21%
RHJA
39
Rice Hall James & Associates
California
$1.05M -$79.3K -5,288 -7%
Charles Schwab
40
Charles Schwab
California
$943K +$247K +16,486 +36%
AI
41
Atom Investors
Texas
$902K +$668K +44,505 +284%
Squarepoint
42
Squarepoint
New York
$895K +$895K +59,690 New
Connor, Clark & Lunn Investment Management (CC&L)
43
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$690K +$243K +16,211 +54%
CBA
44
Coastal Bridge Advisors
Connecticut
$566K -$11.3K -750 -2%
Barclays
45
Barclays
United Kingdom
$560K +$509K +33,946 +992%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$521K +$118K +7,842 +29%
BRA
47
Bender Robert & Associates
California
$521K – – –
JF
48
Jump Financial
Illinois
$500K +$55.8K +3,720 +13%
SAM
49
Shikiar Asset Management
New York
$499K – – –
Marshall Wace
50
Marshall Wace
United Kingdom
$428K +$26K +1,731 +6%
1
2
3 4 5